Kathleen M. Cronin Sells 8,340 Shares of CME Group Inc (CME) Stock

CME Group Inc (NASDAQ:CME) insider Kathleen M. Cronin sold 8,340 shares of the stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $167.54, for a total value of $1,397,283.60. Following the completion of the sale, the insider now directly owns 41,604 shares of the company’s stock, valued at approximately $6,970,334.16. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

CME stock traded down $0.25 during trading hours on Monday, hitting $169.89. 1,733,784 shares of the stock were exchanged, compared to its average volume of 1,878,757. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a market capitalization of $61.08 billion, a price-to-earnings ratio of 24.91, a PEG ratio of 2.15 and a beta of 0.31. CME Group Inc has a 12 month low of $153.90 and a 12 month high of $197.08.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, February 14th. The financial services provider reported $1.77 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.02. The firm had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. CME Group had a return on equity of 9.85% and a net margin of 45.53%. The company’s quarterly revenue was up 37.4% compared to the same quarter last year. During the same quarter last year, the business earned $1.12 EPS. Research analysts expect that CME Group Inc will post 7.07 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 25th. Shareholders of record on Friday, March 8th will be given a dividend of $0.75 per share. This is a boost from CME Group’s previous quarterly dividend of $0.70. The ex-dividend date of this dividend is Thursday, March 7th. This represents a $3.00 annualized dividend and a yield of 1.77%. CME Group’s dividend payout ratio (DPR) is presently 43.99%.

A number of hedge funds have recently bought and sold shares of the business. Peregrine Capital Management LLC increased its position in shares of CME Group by 2.5% in the fourth quarter. Peregrine Capital Management LLC now owns 92,984 shares of the financial services provider’s stock worth $17,492,000 after purchasing an additional 2,267 shares during the period. Legacy Bridge LLC bought a new position in shares of CME Group in the fourth quarter worth $818,000. Swarthmore Group Inc. bought a new position in shares of CME Group in the fourth quarter worth $8,061,000. Fox Run Management L.L.C. bought a new position in shares of CME Group in the fourth quarter worth $250,000. Finally, Parkside Investments LLC increased its position in shares of CME Group by 17.0% in the fourth quarter. Parkside Investments LLC now owns 25,972 shares of the financial services provider’s stock worth $5,012,000 after purchasing an additional 3,782 shares during the period. Hedge funds and other institutional investors own 88.49% of the company’s stock.

CME has been the subject of several recent analyst reports. Berenberg Bank raised CME Group from a “hold” rating to a “buy” rating and set a $220.00 price objective for the company in a report on Tuesday, November 20th. Citigroup started coverage on CME Group in a report on Tuesday, November 20th. They set a “buy” rating and a $220.00 price target for the company. UBS Group downgraded CME Group from a “buy” rating to a “neutral” rating and raised their price target for the company from $185.00 to $204.00 in a report on Wednesday, November 28th. Atlantic Securities started coverage on CME Group in a report on Wednesday, November 28th. They set a “neutral” rating and a $200.00 price target for the company. Finally, Barclays started coverage on CME Group in a report on Tuesday, December 4th. They set an “overweight” rating and a $210.00 price target for the company. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $194.00.

TRADEMARK VIOLATION NOTICE: This piece was first published by WKRB News and is the sole property of of WKRB News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.wkrb13.com/2019/03/18/kathleen-m-cronin-sells-8340-shares-of-cme-group-inc-cme-stock.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Article: Gap Up Stocks

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.